Literature DB >> 28974998

Successful Use of Ketamine for Central Neurogenic Hyperventilation: A Case Report.

G Morgan Jones1,2,3,4, Adam L Wiss2, Nitin Goyal3, Jason J Chang1,3.   

Abstract

This report describes the use of ketamine in a patient with central neurogenic hyperventilation following intracerebral hemorrhage. A 41-year-old man was admitted with right thalamic intracerebral hemorrhage with intraventricular extension requiring emergent external ventricular drain placement. After aggressive management of his neurologic status and other associated complications, the patient subacutely developed an altered respiratory pattern characterized by shallow, rapid breaths. After the use of multiple sedative agents to control respiratory drive had failed, a single 2 mg/kg bolus dose of intravenous ketamine was administered. In the 6 hours prior to ketamine dosing, respiratory rate ranged from 24 to 40 breaths per minute. Within minutes of ketamine administration, respiratory patterns improved and primarily ranged from 16 to 20. Twenty-four hours after ketamine administration, the patient was successfully extubated following 12 days of mechanical ventilation. Further research is needed to determine the widespread applicability of this strategy.

Entities:  

Keywords:  hyperventilation; intracerebral hemorrhage; ketamine

Year:  2017        PMID: 28974998      PMCID: PMC5613869          DOI: 10.1177/1941874417697025

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  16 in total

1.  NMDA receptor activity in utero averts respiratory depression and anomalous long-term depression in newborn mice.

Authors:  C S Poon; Z Zhou; J Champagnat
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 2.  Role of NMDA receptors in development of respiratory control.

Authors:  Karen A Waters; Rita Machaalani
Journal:  Respir Physiol Neurobiol       Date:  2005-11-15       Impact factor: 1.931

3.  Very-low-dose ketamine for the management of pain and sedation in the ICU.

Authors:  Mario De Pinto; Jill Jelacic; William T Edwards
Journal:  J Opioid Manag       Date:  2008 Jan-Feb

4.  Central neurogenic hyperventilation in anti-NMDA receptor encephalitis.

Authors:  Atay Vural; Ethem Murat Arsava; Nese Dericioglu; Mehmet Akif Topcuoglu
Journal:  Intern Med       Date:  2012-10-01       Impact factor: 1.271

5.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

6.  Central neurogenic hyperventilation: a case report and discussion of pathophysiology.

Authors:  Andrew W Tarulli; Chun Lim; Jonathan D Bui; Clifford B Saper; Michael P Alexander
Journal:  Arch Neurol       Date:  2005-10

Review 7.  Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis.

Authors:  Ola Dale; Andrew A Somogyi; Yibai Li; Thomas Sullivan; Yehuda Shavit
Journal:  Anesth Analg       Date:  2012-07-23       Impact factor: 5.108

8.  Chronic dyspnea and hyperventilation in an awake patient with small subcortical infarcts.

Authors:  S C Johnston; V Singh; H J Ralston; W M Gold
Journal:  Neurology       Date:  2001-12-11       Impact factor: 9.910

Review 9.  Remifentanil, ketamine, and fospropofol: a review of alterative continuous infusion agents for sedation in the critically ill.

Authors:  Kerry M Mohrien; G Morgan Jones; Jennifer R MacDermott; Claire V Murphy
Journal:  Crit Care Nurs Q       Date:  2014 Apr-Jun

10.  The effect of ketamine on hypoventilation during deep sedation with midazolam and propofol: a randomised, double-blind, placebo-controlled trial.

Authors:  Gildasio S De Oliveira; Paul C Fitzgerald; Nora Hansen; Shireen Ahmad; Robert J McCarthy
Journal:  Eur J Anaesthesiol       Date:  2014-12       Impact factor: 4.330

View more
  1 in total

1.  Central neurogenic hyperventilation in conscious patients due to CNS neoplasm: a case report and review of the literature on treatment.

Authors:  Joel Neves Briard; Marie-Claude Beaulieu; Émile Lemoine; Camille Beaulieu; Bruno-Pierre Dubé; Sarah Lapointe
Journal:  Neurooncol Pract       Date:  2020-04-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.